Article Text

Download PDFPDF
Dilated cardiomyopathy: immunosuppressive treatment and long term outcome

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Patients with dilated cardiomyopathy (DCM) have a large, poorly contractile, left ventricle. The causes of DCM are unknown but viral infection and/or autoimmunity are the favourite suggestions. Endomyocardial biopsy (EMB) studies have suggested two types of DCM; those with mononuclear infiltration of the myocardium (myocarditis) and those with only fibrosis (cardiomyopathy). With conventional non-immunosuppressive, treatment the outlook for these children has been poor with reported survival rates of 40–75% at 1 year and 37–47% at …

View Full Text